What question did this study set out to answer?

To evaluate the outcomes of Impella 5.5 placement for patients with cardiogenic shock receiving vascular surgery support.

April 25, 2026Journal of the Society for Cardiovascular Angiography & Interventions0 citationsOpen Access

View Full Paper

A-62 | A single center retrospective study of outcomes following Impella 5.5 placement with Vascular Surgery

SJSachin JosephFlorida State University AWAbdul Wahab PRPablo Rengifo-MorenoInterventional / Structural Cardiology

Key Points

To evaluate the outcomes of Impella 5.5 placement for patients with cardiogenic shock receiving vascular surgery support.
Retrospective analysis of patient outcomes after Impella 5.5 placement.
Data sourced from a single center.
Focus on patients undergoing vascular surgery for device implantation.
Improved hemodynamic parameters observed post-Impella 5.5 placement.
Reduced mortality rates associated with timely device implementation in vascular cases.

Abstract

The Impella 5.5 provides robust mechanical circulatory support for patients in cardiogenic shock. In many centers, cardiothoracic (CT) surgical support may be limited or unavailable. In such settings, vascular surgery may be utilized for device implantation. Data on outcomes in this context are sparse.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

A-62 | A single center retrospective study of outcomes following Impella 5.5 placement with Vascular Surgery

Key Points

Abstract

Cite This Study

Also Consider

Also Consider